Bayer drug a “major new player” in prostate cancer (Reuters)
Reuters – An experimental drug from Germany’s Bayer and Norwegian biotech Algeta that prolongs the lives of patients with advanced prostate cancer is a major step forward in treatment of the disease, cancer experts said on Saturday.
View full post on Yahoo! News: Health News
Leave a Reply